Judit Mateu Aniento

7PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsMedical mycologyLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 26, 2026
The Influence of Dietary and Physical Exercise Habits on Melanoma Risk: A Case-Control Study.

|Nov 05, 2025
Exploring blood cell biomarkers in melanoma patients receiving adjuvant anti-PD-1 immunotherapy.

Renan de Jesus Teixeira, Bruna Pereira Sorroche, Vinicius Gonçalves de Souza

|Jun 26, 2025
Integrative Molecular and Immune Profiling in Advanced Unresectable Melanoma: Tumor Microenvironment and Peripheral PD-1+ CD4+ Effector Memory T-Cells as Potential Markers of Response to Immune Checkpoint Inhibitor Therapy.

Manuel Molina-García, María Jesús Rojas-Lechuga, Teresa Torres Moral

|May 19, 2025
Molecular Profiling and Tumor Microenvironment in Sinonasal Mucosal Melanoma as Biomarkers for Enhanced Prognostic Stratification.

Manuel Molina-Garcia, Maria Jesus Rojas-Lechuga, Cristobal Langdon

|Jan 08, 2025
Distinct Transcriptomic and Tumor Microenvironment Profiles in Sinonasal Mucosal Melanoma and Aggressive Cutaneous Melanomas.

Manuel Molina-García, María Jesús Rojas-Lechuga, Teresa Torres Moral

|Sep 24, 2022
Clinical utility of liquid biopsy for monitoring patients with NRAS-mutant medium-to-giant congenital melanocytic nevi.

Neus Calbet-Llopart, Gemma Tell-Martí, Judit Mateu

Pageof 2

Frequent Collaborators

5 joint publications

Susana Puig

5 joint publications

Cristina Carrera

3 joint publications

Rui Milton Patricio da Silva-Júnior

3 joint publications

Sebastian Podlipnik